Market Assessments and Insights


A client had an asset in clinical development that showed activity against multiple tumor types. To guide investment efforts, they needed to assess and prioritize tumor types based on commercial factors.


  • Caravel researched and analyzed several therapeutic areas to assess current and future unmet needs, market size per potential indication, and competition per potential indication.
  • Caravel prioritized tumor types for development efforts, based on competitive entrenchment, estimated clinical profile of company asset against current and future competitors, and access/reimbursement environment by tumor type.